U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07819188) titled 'SCTB35 and SCTB41 With or Without Chemotherapy in Non-Hodgkin Lymphoma' on Sept. 08.
Brief Summary: The purpose of this study is to evaluate the pharmacokinetics, safety, tolerability and efficacy of SCTB35 and SCTB41 With or Without Chemotherapy in non-Hodgkin's lymphoma patients.
Study Start Date: Sept. 30
Study Type: INTERVENTIONAL
Condition:
NHL - Non-Hodgkin's Lymphoma
Intervention:
DRUG: SCTB35 injection
SCTB35 will be subcutaneously administered at a dose as specified
DRUG: SCTB41
SCTB41 will be IV administered at a dose as specified
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Sinocelltech Ltd.
Published by H...